Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene for BCCs in Basal Cell Nevus Syndrome
NCT00489086Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Jul 2004
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tazarotene in basal cell carcinoma (BCC), sponsored by UCSF Benioff Children's Hospital Oakland. Started Jul 2004; status: completed.
02
Drugs
tazarotene
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00489086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489086.